Author

Justin Taylor

Institutions: University of Miami, Sylvester Comprehensive Cancer Center

Observed institutions: University of Miami, Sylvester Comprehensive Cancer Center

OpenAlex ID: A5132874116

Abstract A025: CFON-026, a novel macrocyclic BTK inhibitor disrupts scaffold-dependent signaling and overcomes resistance to BTK-directed therapies

2026 · Erica N. Lamkin, Tim Kong, et al. · Blood Cancer Discovery · 1

Real‐world, multi‐omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS)

2026 · Giulia Maggioni, Gabriele Todisco, et al. · HemaSphere · 1

Abstract B085: Selective oral STK17A inhibitor UMF814A targets a previously unrecognized dark kinase vulnerability in spliceosome-mutant MDS and AML

2026 · Eric Spinetti, Claudia C. Pastrana, et al. · Clinical Cancer Research

Abstract PR002: Dark kinase dependency screening reveals STK17A as a previously unrecognized targetable vulnerability in EGFR-altered glioblastoma

2026 · Eric Spinetti, Christian K. Ramsoomair, et al. · Clinical Cancer Research

Abstract B084: Dark kinase dependency screening reveals STK17A as a previously unrecognized targetable vulnerability in EGFR-altered glioblastoma

2026 · Eric Spinetti, Christian K. Ramsoomair, et al. · Clinical Cancer Research

Abstract PR004: BTK A428D is a recurrent pan-resistance mutation to BTK degraders in clinical trials

2026 · Quinlan Sievers, Hao Lu, et al. · Blood Cancer Discovery

Abstract 7069: Co-targeting menin and LSD1 dismantles oncogenic programs and restores differentiation in MLL-rearranged acute myeloid leukemia.

2026 · Tulasigeri Totiger, Mina Tayari, et al. · Cancer Research

Works count: 7

Citation count: 2

H-index: 1

I10-index: